Immix Biopharma (IMMX) Profit After Tax (2021 - 2026)

Quarterly results put Profit After Tax at -$10.1 million for Q1 2026, down 122.05% from a year ago — trailing twelve months through Mar 2026 was -$35.0 million (down 67.19% YoY), and the annual figure for FY2025 was -$29.4 million, down 36.03%.

Immix Biopharma has reported Profit After Tax over the past 6 years, most recently at -$10.1 million for Q1 2026.

  • Profit After Tax reached -$10.1 million in Q1 2026 per IMMX's latest filing, up from -$10.6 million in the prior quarter.
  • Across five years, Profit After Tax topped out at -$1.3 million in Q1 2022 and bottomed at -$10.6 million in Q4 2025.
  • Median Profit After Tax over the past 5 years was -$4.5 million (2025), compared with a mean of -$5.0 million.
  • Peak annual rise in Profit After Tax hit 83.3% in 2022, while the deepest fall reached 649.04% in 2022.
  • Over 5 years, Profit After Tax stood at -$3.8 million in 2022, then crashed by 33.94% to -$5.1 million in 2023, then rose by 5.45% to -$4.8 million in 2024, then crashed by 121.3% to -$10.6 million in 2025, then rose by 5.28% to -$10.1 million in 2026.
  • Business Quant data shows Profit After Tax for IMMX at -$10.1 million in Q1 2026, -$10.6 million in Q4 2025, and -$7.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -2.99 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 30.90 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.03 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 727.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -3.63 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 205.99 Mn
10 Immix Biopharma 476.17 Mn 476.17 Mn - -10.09 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -10.09 Mn
Dec 31, 2025 -10.65 Mn
Sep 30, 2025 -7.60 Mn
Jun 30, 2025 -6.62 Mn
Mar 31, 2025 -4.54 Mn
Dec 31, 2024 -4.81 Mn
Sep 30, 2024 -7.15 Mn
Jun 30, 2024 -4.41 Mn
Mar 31, 2024 -5.33 Mn
Dec 31, 2023 -5.09 Mn
Sep 30, 2023 -4.28 Mn
Jun 30, 2023 -3.60 Mn
Mar 31, 2023 -2.50 Mn
Dec 31, 2022 -3.80 Mn
Sep 30, 2022 -1.54 Mn
Jun 30, 2022 -1.56 Mn
Mar 31, 2022 -1.33 Mn
Dec 31, 2021 -22.76 Mn
Sep 30, 2021 -403,265.00
Jun 30, 2021 -208,638.00
Mar 31, 2021 -1.02 Mn